FM
Mach, François
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| 2D echocardiography video to 3D heart shape reconstruction for clinical application | Medical image analysis | 2025 | 9 | 18 | |||
| Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction : a target trial emulation from a real-world cohort | European journal of preventive cardiology | 2025 | 3 | 106 | |||
| Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes | European journal of clinical investigation | 2025 | 1 | 0 | |||
| Recruiting medical, dental, and biomedical students as first responders in the immediate aftermath of the COVID-19 pandemic : prospective follow-up study | JMIR medical education | 2025 | 64 | 143 | |||
| Left atrial wall shear stress correlates with fibrosis in patients with atrial fibrillation | Nature cardiovascular research | 2025 | 53 | 120 | |||
| Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement : association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trial | European journal of preventive cardiology | 2025 | 27 | 33 | |||
| Diversité de la cardiologie contemporaine | Revue médicale suisse | 2024 | 15 | 15 | |||
| A systematic review and meta-analysis of differences between men and women in short-term outcomes following coronary artery bypass graft surgery | Scientific reports | 2024 | 167 | 148 | |||
| Addressing residual risk beyond statin therapy : New targets in the management of dyslipidaemias - A report from the European Society of Cardiology Cardiovascular Round Table | Journal of clinical lipidology | 2024 | 6 | 0 | |||
| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2024 | 85 | 73 | |||
| Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial | Research and practice in thrombosis and haemostasis | 2024 | 74 | 126 | |||
| Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-study | Catheterization and cardiovascular interventions | 2024 | 7 | 0 | |||
| Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes | Atherosclerosis plus | 2024 | 11 | 15 | |||
| Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome | European journal of preventive cardiology | 2024 | 63 | 121 | |||
| Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromes | European journal of clinical investigation | 2024 | 6 | 10 | |||
| Window of opportunity for developing effective medical intervention for calcific aortic valve disease | European heart journal | 2024 | 20 | 18 | |||
| Smoking cessation in people with and without diabetes after acute coronary syndrome | Nicotine & tobacco research | 2023 | 76 | 30 | |||
| Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium) | Frontiers in cardiovascular medicine | 2023 | 96 | 24 | |||
| Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans | Cardiovascular research | 2023 | 70 | 54 | |||
| Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Diseaseand cardiovascular risk : a translational study | ESC (European Society of Cardiology) Congress 2023 | 2023 | 5 | 0 | |||
| Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes | European heart journal. Acute cardiovascular care | 2023 | 58 | 177 | |||
| Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study | Journal of translational medicine | 2023 | 142 | 148 | |||
| « Heart Team » : le cœur de la cardiologie | Revue médicale suisse | 2023 | 7 | 14 | |||
| Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes : A post hoc analysis of the CAPTURE study | Diabetes, obesity & metabolism | 2023 | 111 | 224 | |||
| Enoxaparin for outpatients with COVID-19 : 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial | Thrombosis research | 2023 | 102 | 126 | |||
| In-hospital initiation of PCSK9 inhibitors in ACS : pros and cons | EuroIntervention | 2023 | 96 | 213 | |||
| No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab | PloS one | 2022 | 101 | 95 | |||
| A Short Intervention and an Interactive e-Learning Module to Motivate Medical and Dental Students to Enlist as First Responders: Implementation Study | JMIR. Journal of medical internet research | 2022 | 308 | 262 | |||
| Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I | Research and practice in thrombosis and haemostasis | 2022 | 194 | 427 | |||
| Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study | Swiss medical weekly | 2022 | 74 | 61 | |||
| Effectiveness, adherence, and safety of evolocumab in a swiss multicenter prospective observational study | Advances in therapy | 2022 | 223 | 224 | |||
| Combination lipid-lowering therapy as first-line strategy in very high-risk patients | European heart journal | 2022 | 261 | 3 | |||
| The 'ten commandments' for the 2021 ESC Guidelines on CVD prevention | European heart journal | 2022 | 125 | 271 | |||
| High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD? | 90th European Atherosclerosis Society (EAS) congress | 2022 | 157 | 0 | |||
| Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease | International journal of molecular sciences | 2022 | 195 | 204 | |||
| Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE) : a single-arm, multicentre, open-label extension of HAUSER-RCT | The Lancet. Diabetes & endocrinology | 2022 | 96 | 0 | |||
| Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey | European journal of preventive cardiology | 2022 | 203 | 0 | |||
| European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology | European journal of preventive cardiology | 2022 | 260 | 0 | |||
| Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial | The lancet. Haematology | 2022 | 216 | 258 | |||
| Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells | Cells | 2022 | 223 | 359 | |||
| Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study | PloS one | 2022 | 99 | 133 | |||
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | European journal of preventive cardiology | 2022 | 425 | 3,677 | |||
| Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis : a European Atherosclerosis Society consensus statement | European heart journal | 2022 | 116 | 482 | |||
| Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS)-A phase II, randomized, double-blind, multi-center, placebo-controlled trial | The American heart journal | 2022 | 163 | 0 | |||
| Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes | European heart journal | 2022 | 185 | 2 | |||
| Dernières recommandations européennes sur les dyslipidémies | Revue médicale suisse | 2022 | 395 | 1,068 | |||
| Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis | Cardiovascular research | 2022 | 210 | 0 | |||
| Inclisiran in primary prevention : reality or fiction ? | European heart journal | 2022 | 132 | 0 | |||
| It's never too early to beat your low-density lipoprotein cholesterol | Archives of cardiovascular diseases | 2021 | 154 | 0 | |||
| Impact of malignancy on clinical outcomes in patients with acute coronary syndromes | International journal of cardiology | 2021 | 191 | 0 | |||
| Reduced adrenal stress response in patients on PCSK9 inhibitor therapy | Atherosclerosis | 2021 | 238 | 0 | |||
| Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure | Journal of clinical medicine | 2021 | 231 | 97 | |||
| Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial | The American heart journal | 2021 | 241 | 0 | |||
| Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease | Open Heart | 2021 | 251 | 185 | |||
| Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland | Preventive medicine reports | 2021 | 205 | 138 | |||
| Prognostic value of total testosterone levels in patients with acute coronary syndromes | European Journal of Preventive Cardiology | 2021 | 489 | 3 | |||
| Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events | Atherosclerosis | 2021 | 225 | 68 | |||
| La réadaptation cardiaque : un programme multidisciplinaire de prévention cardiovasculaire indispensable | Revue médicale suisse | 2021 | 297 | 517 | |||
| Une baisse du cholestérol LDL de longue durée : enfin le silence | Revue médicale suisse | 2021 | 292 | 0 | |||
| Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromes | European heart journal. Acute cardiovascular care | 2021 | 192 | 249 | |||
| Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2021 | 211 | 155 | |||
| NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis | International journal of molecular sciences | 2021 | 270 | 207 | |||
| Lipoprotein(a) levels are not independently associated with endogenous steroid hormone levels, in contrast to other non-genetic and genetic factors: the population-based SKIPOGH study | European heart journal | 2021 | 243 | 0 | |||
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | European heart journal | 2021 | 657 | 9 | |||
| Changes of lipoprotein(a) levels with endogenous steroid hormones | European journal of clinical investigation | 2021 | 306 | 345 | |||
| New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? | Atherosclerosis | 2021 | 223 | 326 | |||
| Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure | Reviews in endocrine and metabolic disorders | 2021 | 213 | 318 | |||
| Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease | 89th Europen Society of Atherosclerosis (EAS) | 2021 | 142 | 0 | |||
| CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients | Atherosclerosis | 2021 | 170 | 56 | |||
| Impact of COVID-19 on quality of life | e-Journal of Cardiology Practice | 2021 | 213 | 48 | |||
| Novel blood biomarkers for a diagnostic workup of acute aortic dissection | Diagnostics | 2021 | 174 | 112 | |||
| Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode | Schweizerische medizinische Wochenschrift | 2021 | 291 | 134 | |||
| Air pollution triggers inflammation and cardiovascular events: now is the time to act | European heart journal | 2021 | 164 | 0 | |||
| ARN : du prix Nobel au traitement, la cardiologie au devant de la scène | Revue médicale suisse | 2021 | 346 | 92 | |||
| Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines | European journal of preventive cardiology | 2021 | 164 | 0 | |||
| Improving 1-year mortality prediction in ACS patients using machine learning | European heart journal. Acute cardiovascular care | 2021 | 173 | 1 | |||
| Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet | Cardiovascular Research | 2021 | 222 | 158 | |||
| Antibodies against apolipoprotein a-1 as disruptors of cellular cholesterol homeostasis promoting foam cell formation | 88th EAS (European Atherosclerosis Society) Congress | 2020 | 67 | 0 | |||
| Optimal timing of invasive coronary angiography following NSTEMI | Journal of interventional cardiology | 2020 | 238 | 162 | |||
| Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial | Trials | 2020 | 77 | 30 | |||
| Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques | International Journal of Molecular Sciences | 2020 | 243 | 128 | |||
| Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trial | JAMA cardiology | 2020 | 285 | 448 | |||
| À propos du bloc-notes: « Statines, la médecine immobile » | Revue médicale suisse | 2020 | 159 | 0 | |||
| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European heart journal | 2020 | 328 | 1,366 | |||
| Cognition After Lowering LDL-Cholesterol With Evolocumab | Journal of the American College of Cardiology | 2020 | 157 | 0 | |||
| Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study | European heart journal. Acute cardiovascular care | 2020 | 182 | 0 | |||
| A Short Intervention Followed by an Interactive E-Learning Module to Motivate Medical Students to Enlist as First Responders: Protocol for a Prospective Implementation Study | JMIR research protocols | 2020 | 315 | 407 | |||
| Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort | International journal of cardiology | 2020 | 222 | 0 | |||
| Intravascular lithotripsy to treat an ostial left main coronary artery stenosis due to porcelain aorta in a patient with congenital high-density lipoprotein deficiency | Anatolian Journal of Cardiology | 2020 | 235 | 147 | |||
| Au Cœur du Covid-19 | Revue médicale suisse | 2020 | 235 | 0 | |||
| An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial | JAMA cardiology | 2020 | 151 | 0 | |||
| Prognosis of patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes | Journal of cardiovascular translational research | 2020 | 172 | 125 | |||
| Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression | Scientific Reports | 2020 | 224 | 226 | |||
| Atherosclerotic plaque vulnerability is increased in mouse model of lupus | Scientific Reports | 2020 | 324 | 235 | |||
| Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors | International journal of cardiology | 2020 | 165 | 0 | |||
| Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 | Thrombosis and Haemostasis | 2020 | 251 | 0 | |||
| Roadmap for the treatment of heart failure patients after hospital discharge: an interdisciplinary consensus paper | Schweizerische medizinische Wochenschrift | 2020 | 264 | 217 | |||
| Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population | Clinical & translational immunology | 2020 | 207 | 158 | |||
| Potential of lipoprotein(a)-lowering strategies in treating coronary artery disease | Drugs | 2020 | 182 | 0 | |||
| Haut les cœurs ! | Revue médicale suisse | 2020 | 77 | 62 | |||
| Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence | Journal of cardiovascular medicine | 2020 | 223 | 0 | |||
| C-terminus apoa-1 mimetic peptides to detect cognate auto-antibodies and reverse HIV-induced foam cell formation | Atherosclerosis | 2020 | 252 | 0 | |||
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | 2020 | 291 | 1 | |||
| Impact of the COVID-19 pandemic on acute coronary syndromes | Swiss Medical Weekly | 2020 | 332 | 162 | |||
| Determinants of hospital length of stay after transcatheter aortic valve implantation with self-expanding prostheses: a prospective, single centre observational study | Swiss medical weekly | 2019 | 98 | 158 | |||
| Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography | Catheterization and Cardiovascular Interventions | 2019 | 325 | 0 | |||
| Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects | Journal of clinical medicine | 2019 | 240 | 102 | |||
| Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort | Atherosclerosis | 2019 | 438 | 1 | |||
| Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromes | Journal of Clinical Medicine | 2019 | 440 | 194 | |||
| Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes | European Journal of Clinical Investigation | 2019 | 400 | 2 | |||
| Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation | Journal of clinical medicine | 2019 | 241 | 188 | |||
| Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention | PloS one | 2019 | 58 | 111 | |||
| Prognostic value of the echocardiographic probability of pulmonary hypertension in patients with acute decompensated heart failure | Journal of clinical medicine | 2019 | 401 | 86 | |||
| Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients | Journal of Infection | 2018 | 581 | 1 | |||
| Impact of long distance rowing on biological health: A pilot study | Clinical Biochemistry | 2018 | 568 | 0 | |||
| Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation | The Journal of International Medical Research | 2018 | 428 | 237 | |||
| Etat des connaissances en 2018 sur les anticorps anti-PCSK9 | Revue médicale suisse | 2018 | 235 | 154 | |||
| Serum cardiovascular risk biomarkers in pre-pubertal obese children | European Journal of Clinical Investigation | 2018 | 354 | 417 | |||
| Follicular regulatory T cell in atherosclerosis | Journal of Leukocyte Biology | 2018 | 355 | 201 | |||
| Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease | International Journal of Molecular Sciences | 2018 | 613 | 240 | |||
| Activité physique au long cours après un infarctus du myocarde : un défi permanent | Revue médicale suisse | 2017 | 661 | 535 | |||
| Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms | Frontiers in Immunology | 2017 | 471 | 244 | |||
| Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population | Arteriosclerosis, Thrombosis, and Vascular Biology | 2017 | 517 | 0 | |||
| Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease | New England Journal of Medicine | 2017 | 523 | 1,173 | |||
| Alamandine abrogates neutrophil degranulation in atherosclerotic mice | European Journal of Clinical Investigation | 2017 | 453 | 617 | |||
| Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment–Elevation Myocardial Infarction Role of Differential MicroRNA-378 Expression | Arteriosclerosis, Thrombosis, and Vascular Biology | 2017 | 353 | 192 | |||
| Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney | Hypertension | 2017 | 336 | 0 | |||
| Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction | European Heart Journal | 2017 | 353 | 242 | |||
| The fear of dying and occurrence of posttraumatic stress symptoms after an acute coronary syndrome: A prospective observational study | Journal of health psychology | 2017 | 555 | 716 | |||
| GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na + -Ca 2+ exchanger and endoplasmic reticulum Ca 2+ refilling | Vascular Pharmacology | 2017 | 332 | 262 | |||
| 4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability | Magnetic Resonance Imaging | 2017 | 563 | 2 | |||
| Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | 2016 | 563 | 0 | |||
| Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | 2016 | 590 | 1 | |||
| Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study | Thrombosis and haemostasis | 2016 | 566 | 7 | |||
| Prognostic value of PCSK9 levels in patients with acute coronary syndromes | European heart journal | 2016 | 630 | 2 | |||
| Health utility indexes in patients with acute coronary syndromes | Open heart | 2016 | 562 | 279 | |||
| Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay | PloS one | 2016 | 856 | 412 | |||
| Myeloid IL-10 receptor signalling as pro-atherogenic factor modulating cholesterol homeostasis | Thrombosis and haemostasis | 2016 | 506 | 2 | |||
| The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals | Nature Genetics | 2016 | 351 | 0 | |||
| Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis | Thrombosis and haemostasis | 2016 | 729 | 1 | |||
| Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43 | Cardiovascular research | 2016 | 699 | 6 | |||
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | 2016 | 633 | 6 | |||
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | 2016 | 770 | 685 | |||
| Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | 2016 | 517 | 200 | |||
| Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures | European Journal of Internal Medicine | 2016 | 510 | 1 | |||
| Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 | Antioxidants & redox signaling | 2015 | 604 | 0 | |||
| The role of adipocytokines in atherogenesis and atheroprogression | Current drug targets | 2015 | 548 | 0 | |||
| Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis | European journal of clinical investigation | 2015 | 533 | 0 | |||
| Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population | European journal of clinical investigation | 2015 | 658 | 0 | |||
| Use and role of monoclonal antibodies and other biologics in preventive cardiology | Schweizerische medizinische Wochenschrift | 2015 | 663 | 356 | |||
| Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury | PloS one | 2015 | 678 | 262 | |||
| Leptin/adiponectin ratio predicts post-stroke neurological outcome | European journal of clinical investigation | 2015 | 602 | 1 | |||
| Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice | Vascular pharmacology | 2015 | 560 | 1 | |||
| Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | 2015 | 669 | 0 | |||
| Genetic studies of body mass index yield new insights for obesity biology | Nature | 2015 | 630 | 0 | |||
| Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways | European heart journal | 2015 | 659 | 2 | |||
| Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | 2015 | 748 | 0 | |||
| Editorial: update on inflammatory targets modulating atherogenesis | Current drug targets | 2015 | 508 | 0 | |||
| Impact of propofol anaesthesia on cytokine expression profiles in the developing rat brain: a randomised placebo-controlled experimental in-vivo study | European journal of anaesthesiology | 2015 | 557 | 0 | |||
| Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways | Vascular pharmacology | 2015 | 852 | 4 | |||
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | 2015 | 793 | 0 | |||
| Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury | The journal of sexual medicine | 2015 | 593 | 0 | |||
| Update on the role of neutrophils in atherosclerotic plaque vulnerability | Current drug targets | 2015 | 507 | 0 | |||
| The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? | PloS one | 2015 | 562 | 379 | |||
| Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | 2015 | 608 | 0 | |||
| Mon patient est trop âgé pour une statine : mythes et réalités | Revue médicale suisse | 2015 | 478 | 0 | |||
| Role of matrix metalloproteinases in animal models of ischemic stroke | Current vascular pharmacology | 2015 | 540 | 0 | |||
| Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation | Pacing and clinical electrophysiology | 2015 | 598 | 0 | |||
| Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes | Atherosclerosis | 2015 | 789 | 576 | |||
| Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | 2015 | 634 | 5 | |||
| Update on the efficacy of statin treatment in acute coronary syndromes | European journal of clinical investigation | 2014 | 602 | 0 | |||
| Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice | Cardiovascular research | 2014 | 726 | 5 | |||
| Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | 2014 | 655 | 0 | |||
| Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | 2014 | 791 | 0 | |||
| Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case | World journal of clinical cases | 2014 | 669 | 0 | |||
| Potential pathophysiological role for the vitamin D deficiency in essential hypertension | World journal of cardiology | 2014 | 586 | 0 | |||
| Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients | European journal of internal medicine | 2014 | 562 | 0 | |||
| La testostérone : un traitement pour la prévention des maladies cardiovasculaires ? | Revue médicale suisse | 2014 | 506 | 0 | |||
| Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques | Thrombosis and haemostasis | 2014 | 606 | 0 | |||
| Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice | Journal of cerebral blood flow and metabolism | 2014 | 776 | 384 | |||
| Inferior vena cava parameters predict re-admission in ischaemic heart failure | European journal of clinical investigation | 2014 | 619 | 0 | |||
| Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis | Thrombosis and haemostasis | 2014 | 652 | 0 | |||
| Left atrial dissection after mitral valve replacement | European heart journal | 2014 | 652 | 0 | |||
| Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis | Mediators of inflammation | 2014 | 837 | 405 | |||
| Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases | Current medicinal chemistry | 2014 | 766 | 0 | |||
| Advanced glycation end products play adverse proinflammatory activities in osteoporosis | Mediators of inflammation | 2014 | 534 | 599 | |||
| Angiotensin II receptor antagonists in acute coronary syndromes | European journal of clinical investigation | 2014 | 518 | 0 | |||
| Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke | Thrombosis and haemostasis | 2014 | 652 | 0 | |||
| The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome | Thrombosis and haemostasis | 2013 | 573 | 0 | |||
| Pathophysiological role of neutrophils in acute myocardial infarction | Thrombosis and haemostasis | 2013 | 611 | 0 | |||
| Discovery and refinement of loci associated with lipid levels | Nature genetics | 2013 | 677 | 0 | |||
| Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines | European heart journal | 2013 | 588 | 0 | |||
| Update on the protective molecular pathways improving pancreatic beta-cell dysfunction | Mediators of inflammation | 2013 | 698 | 286 | |||
| Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serum | Mediators of inflammation | 2013 | 535 | 0 | |||
| Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis | Journal of periodontal research | 2013 | 775 | 1 | |||
| Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction | Antioxidants & redox signaling | 2013 | 784 | 807 | |||
| Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy | Thrombosis and haemostasis | 2013 | 740 | 1 | |||
| Role of matrix metalloproteinase-8 in atherosclerosis | Mediators of inflammation | 2013 | 543 | 291 | |||
| Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity | Mediators of inflammation | 2013 | 565 | 267 | |||
| Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice | Thrombosis and haemostasis | 2013 | 758 | 0 | |||
| Pathophysiological role of the renin-angiotensin system on erectile dysfunction | European journal of clinical investigation | 2013 | 532 | 754 | |||
| Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome | Mediators of inflammation | 2013 | 555 | 215 | |||
| Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma | World journal of gastroenterology | 2013 | 584 | 0 | |||
| An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes | Mediators of inflammation | 2013 | 519 | 442 | |||
| Inflammation is a key pathophysiological feature of metabolic syndrome | Mediators of inflammation | 2013 | 540 | 210 | |||
| An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia | The journal of sexual medicine | 2013 | 546 | 0 | |||
| Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases | Thrombosis and haemostasis | 2013 | 504 | 0 | |||
| Update on evidence for treatment with ranolazine in stable angina | Schweizerische medizinische Wochenschrift | 2013 | 499 | 0 | |||
| Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice | Journal of cerebral blood flow and metabolism | 2013 | 727 | 0 | |||
| Role of the renin-angiotensin system on abdominal aortic aneurysms | European journal of clinical investigation | 2013 | 504 | 0 | |||
| Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice | Clinical & developmental immunology | 2013 | 571 | 0 | |||
| Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury | Journal of Molecular and Cellular Cardiology | 2013 | 653 | 0 | |||
| Cardiopathies congénitales de l'âge adulte: nouvelle population de patients, prise en charge multidisciplinaire | Revue médicale suisse | 2013 | 556 | 0 | |||
| The vulnerable coronary plaque: update on imaging technologies | Thrombosis and haemostasis | 2013 | 454 | 0 | |||
| Lack of association between connexin40 polymorphisms and coronary artery disease | Atherosclerosis | 2012 | 597 | 5 | |||
| Serum resistin and inflammatory and endothelial activation markers in obese adolescents | The Journal of pediatrics | 2012 | 628 | 0 | |||
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | 2012 | 737 | 73 | |||
| Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells | Journal of Molecular and Cellular Cardiology | 2012 | 782 | 7 | |||
| Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals | Mediators of inflammation | 2012 | 655 | 294 | |||
| Manganese kinetics demonstrated double contrast in acute but not in chronic infarction in a mouse model of myocardial occlusion reperfusion | NMR in biomedicine | 2012 | 647 | 0 | |||
| Coronary Vasomotor Control in Obesity and Morbid Obesity | JACC. Cardiovascular imaging | 2012 | 764 | 672 | |||
| Editorial: update on inflammatory processes governing atherosclerotic plaque vulnerability and reperfusion injury | Current pharmaceutical biotechnology | 2012 | 408 | 0 | |||
| Statins in the treatment of acute ischemic stroke | Current pharmaceutical biotechnology | 2012 | 515 | 0 | |||
| Role of renin-angiotensin system in inflammation, immunity and aging | Current pharmaceutical design | 2012 | 524 | 0 | |||
| Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium | Current signal transduction therapy | 2012 | 586 | 0 | |||
| Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury | European journal of clinical investigation | 2012 | 629 | 0 | |||
| Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer | World journal of gastroenterology | 2012 | 503 | 0 | |||
| Role of cytokines and chemokines in non-alcoholic fatty liver disease | World journal of gastroenterology | 2012 | 392 | 1 | |||
| CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice | European heart journal | 2012 | 691 | 1 | |||
| Statins and stent thrombosis | Schweizerische medizinische Wochenschrift | 2012 | 484 | 0 | |||
| Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight | Journal of nuclear cardiology | 2012 | 698 | 318 | |||
| Update on the role of cannabinoid receptors after ischemic stroke | Mediators of inflammation | 2012 | 515 | 1 | |||
| Curing by Burning: What to expect from renal denervation in the treatment of arterial hypertension | Kardiovaskuläre Medizin | 2012 | 618 | 0 | |||
| Elevated E-selectin and diastolic blood pressure in diabetic children | European journal of clinical investigation | 2012 | 651 | 0 | |||
| Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction | Journal of internal medicine | 2012 | 671 | 2 | |||
| The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques | European heart journal | 2012 | 747 | 0 | |||
| Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology | Expert review of cardiovascular therapy | 2012 | 593 | 0 | |||
| The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases | Thrombosis and haemostasis | 2012 | 439 | 0 | |||
| Fondaparinux versus enoxaprin in the management of acute coronary syndromes in Switzerland: A cost comparison analysis | Schweizerische medizinische Wochenschrift | 2012 | 523 | 0 | |||
| Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation | Circulation | 2012 | 512 | 0 | |||
| Molecular imaging of matrix metalloproteinases in atherosclerotic plaques | Thrombosis and haemostasis | 2012 | 491 | 0 | |||
| High time-resolved cardiac functional imaging using temporal regularization for small animal on a clinical 3T scanner | IEEE transactions on biomedical engineering | 2012 | 620 | 0 | |||
| Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability | Thrombosis and haemostasis | 2012 | 796 | 0 | |||
| Inflammatory cardiovascular risk biomarkers: update on novelties and limitations | Mediators of inflammation | 2012 | 514 | 0 | |||
| Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels | Endocrinology | 2012 | 712 | 0 | |||
| Sélection et suivi prétransplantation des patients candidats à la greffe cardique en Suisse romande | Revue médicale suisse | 2011 | 615 | 0 | |||
| Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics | Thrombosis and haemostasis | 2011 | 724 | 0 | |||
| Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability | European heart journal | 2011 | 674 | 2 | |||
| Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome | American journal of physiology: endocrinology and metabolism | 2011 | 668 | 0 | |||
| Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice | Journal of medical genetics | 2011 | 674 | 0 | |||
| Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity | European heart journal | 2011 | 671 | 0 | |||
| Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling | European journal of clinical investigation | 2010 | 566 | 0 | |||
| Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice | Journal of Molecular and Cellular Cardiology | 2010 | 737 | 0 | |||
| Un projet multicentrique suisse pour améliorer la prévention et la récidive après un syndrome coronarien aigu | Revue médicale suisse | 2010 | 650 | 0 | |||
| In vivo labelling of resting monocytes in the reticuloendothelial system with fluorescent iron oxide nanoparticles prior to injury reveals that they are mobilized to infarcted myocardium | European heart journal | 2010 | 545 | 0 | |||
| Novel treatment strategy with direct renin inhibition against heart failure | Panminerva Medica | 2010 | 489 | 0 | |||
| La cardiologie dans le rythme | Revue médicale suisse | 2010 | 494 | 0 | |||
| Le clopidogrel et ses différents sets: existe-t-il une pertinence clinique? | Revue médicale suisse | 2010 | 615 | 0 | |||
| Stairs instead of elevators at workplace: cardioprotective effects of a pragmatic intervention | European journal of cardiovascular prevention & rehabilitation | 2010 | 1,025 | 0 | |||
| New evidence for nicotinic acid treatment to reduce atherosclerosis | Expert review of cardiovascular therapy | 2010 | 1,042 | 0 | |||
| Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT | Nuclear-Medizin | 2010 | 649 | 0 | |||
| High-Throughput Phospholipidic Fingerprinting by Online Desorption of Dried Spots and Quadrupole-Linear Ion Trap Mass Spectrometry: Evaluation of Atherosclerosis Biomarkers in Mouse Plasma | Analytical chemistry | 2010 | 632 | 0 | |||
| Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS) | Sleep & breathing | 2010 | 607 | 406 | |||
| Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | 2010 | 908 | 3 | |||
| Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice | Arteriosclerosis, thrombosis, and vascular biology | 2010 | 640 | 0 | |||
| Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction | European heart journal | 2010 | 708 | 0 | |||
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | 2010 | 606 | 0 | |||
| Myocardial infarction quantification with Manganese-Enhanced MRI (MEMRI) in mice using a 3T clinical scanner | NMR in biomedicine | 2010 | 594 | 2 | |||
| Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT | Journal of nuclear cardiology | 2010 | 676 | 258 | |||
| Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke | Stroke | 2010 | 665 | 0 | |||
| Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification | Critical pathways in cardiology | 2010 | 747 | 0 | |||
| Prehospital emergency physician activation of interventional cardiology team reduces door-to-balloon time in ST-elevation myocardial infarction | Schweizerische medizinische Wochenschrift | 2010 | 613 | 170 | |||
| Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance | Current vascular pharmacology | 2009 | 531 | 0 | |||
| CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion | Journal of Molecular and Cellular Cardiology | 2009 | 779 | 0 | |||
| Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome | Diabetes, obesity & metabolism | 2009 | 580 | 0 | |||
| Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis | Rheumatology | 2009 | 664 | 0 | |||
| Ezetimibe/simvastatin | Expert opinion on drug safety | 2009 | 535 | 0 | |||
| Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk | Pharmacological Reports | 2009 | 549 | 0 | |||
| Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis | Circulation | 2009 | 631 | 0 | |||
| Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusion | Journal of nuclear cardiology | 2009 | 655 | 443 | |||
| HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | 2009 | 662 | 0 | |||
| Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin | Clinical and experimental pharmacology & physiology | 2009 | 718 | 0 | |||
| The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies | Mediators of inflammation | 2009 | 609 | 0 | |||
| Atherosclerosis is an inflammatory disease | Seminars in immunopathology | 2009 | 844 | 232 | |||
| Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes | Rheumatology | 2009 | 658 | 0 | |||
| Update on statin-mediated anti-inflammatory activities in atherosclerosis | Seminars in immunopathology | 2009 | 516 | 533 | |||
| Suivi du patient après transplantation cardiaque : monitoring et adaptation de l'immunosuppression | Revue médicale suisse | 2009 | 624 | 0 | |||
| Obstructive sleep apnea and atherosclerosis | Progress in cardiovascular diseases | 2009 | 644 | 0 | |||
| Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes | Hypertension | 2009 | 590 | 0 | |||
| Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis | Atherosclerosis | 2009 | 636 | 0 | |||
| Percutaneous retrieval of intravascular and intracardiac foreign bodies with a dedicated three-dimensional snare: a 3-year single center experience | Catheterization and cardiovascular interventions | 2009 | 611 | 0 | |||
| The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury | Thrombosis and haemostasis | 2009 | 590 | 0 | |||
| Statins, ACE inhibitors and ARBs in cardiovascular disease | Baillière's best practice & research. Clinical endocrinology & metabolism | 2009 | 607 | 0 | |||
| Stair use for cardiovascular disease prevention | European journal of cardiovascular prevention & rehabilitation | 2009 | 655 | 0 | |||
| Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways | Journal of Biomedicine and Biotechnology | 2009 | 536 | 0 | |||
| Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness | Thrombosis research | 2008 | 633 | 0 | |||
| Cannabinoid receptors in acute and chronic complications of atherosclerosis | British journal of pharmacology | 2008 | 630 | 0 | |||
| A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy | Human mutation | 2008 | 757 | 0 | |||
| Renin-angiotensin system blockade and contrast-induced renal toxicity | JN. Journal of Nephrology | 2008 | 607 | 0 | |||
| Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability | Mediators of inflammation | 2008 | 599 | 532 | |||
| Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways | Cellular signalling | 2008 | 709 | 0 | |||
| C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes | Journal of leukocyte biology | 2008 | 645 | 0 | |||
| New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor | Clinical interventions in aging | 2008 | 591 | 228 | |||
| Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome | Clinical science | 2008 | 773 | 9 | |||
| PARP1 is required for adhesion molecule expression in atherogenesis | Cardiovascular research | 2008 | 640 | 184 | |||
| The role of the endocannabinoid system in atherosclerosis | Journal of neuroendocrinology | 2008 | 633 | 0 | |||
| Emerging Roles for Connexins in Hypertension | Current hypertension reviews | 2008 | 647 | 0 | |||
| CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways | American journal of physiology. Heart and circulatory physiology | 2008 | 630 | 0 | |||
| Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis | Circulation research | 2008 | 590 | 0 | |||
| A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice | Arteriosclerosis, thrombosis, and vascular biology | 2008 | 695 | 0 | |||
| Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques | Thrombosis and haemostasis | 2007 | 615 | 244 | |||
| Atorvastatin treatment and vaccination efficacy | Journal of clinical pharmacology | 2007 | 612 | 0 | |||
| Soluble CD40 ligand in prediction of acute severe pancreatitis | World journal of gastroenterology | 2006 | 829 | 450 | |||
| L'apport de la génétique moléculaire en cardiologie clinique : l'exemple de la cardiomyopathie hypertrophique | Revue médicale suisse | 2005 | 576 | 1 | |||
| Late cardiac tamponade after percutaneous closure of a patent foramen ovale | European journal of echocardiography | 2005 | 558 | 348 | |||
| Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia | Critical care medicine | 2004 | 610 | 1 | |||
| Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease | Journal of autoimmunity | 2004 | 543 | 0 | |||
| Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice | Circulation | 2003 | 564 | 1 | |||
| Cd40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis-associated lung injury | Gastroenterology | 2001 | 795 | 0 |
